FFCP PHASE2:Hg19::chr8:37963407..37963454,+
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p2@ASH2L |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_2_at_ASH2L_5end |
| Coexpression cluster: | C4750_testicular_mesothelioma_chronic_teratocarcinoma_Reticulocytes_Mesothelial_Hepatic |
| Association with transcript: | -2bp_to_ENST00000521652_5end |
| EntrezGene: | ASH2L |
| HGNC: | 744 |
| UniProt: | NA |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p2@ASH2L |
|---|
0
20
40
60
80
100
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| disease of cellular proliferation | 5.07e-18 | 239 |
| cancer | 7.49e-18 | 235 |
| hematologic cancer | 2.74e-08 | 51 |
| immune system cancer | 2.74e-08 | 51 |
| leukemia | 3.64e-08 | 39 |
| organ system cancer | 1.09e-07 | 137 |
Showing 1 to 6 of 6 entries
